# Hpv Type16-18 L1 Protein

## Cervarix HPV 0.5mL/dose

| 藥物代碼 | ICER |
| :--- | :--- |
| 適應症 | Prevention of cervical cancer in females 10-25 years, by protecting against incident & persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance \(ASC-US\) & cervical intraepithelial neoplasia \(CIN\), CIN1 & pre-cancerous lesions \(CIN2 & CIN3\) caused by HPV Types 16 & 18. |
| 副作用 | Headache, GI disturbances, itch, rash, myalgia, arthralgia, inj site reactions, fatigue, fever. |
| 禁忌 | Subjects with known hypersensitivity to any component of Cervarix. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | 3 separated doses given at baseline, 1, and 6 months by intramuscular injection Girls between the ages of 9 and 14 can also take two doses of vaccination, the second dose should be given 5 to 13 months after the first dose. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer's labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | No \(Limited\) Human Data - Probably Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1. 使用前應先充分搖勻。 2. 應以肌肉注射的方式施打於上臂三角肌部位。 |

## Cervarix \(HPVGovernment\) 0.5mL/dose

| 藥物代碼 | ICER0 |
| :--- | :--- |
| 適應症 | Prevention of cervical cancer in females 10-25 years, by protecting against incident & persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance \(ASC-US\) & cervical intraepithelial neoplasia \(CIN\), CIN1 & pre-cancerous lesions \(CIN2 & CIN3\) caused by HPV Types 16 & 18. |
| 副作用 | Headache, GI disturbances, itch, rash, myalgia, arthralgia, inj site reactions, fatigue, fever. |
| 禁忌 | Subjects with known hypersensitivity to any component of Cervarix. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | 3 separated doses given at baseline, 1, and 6 months by intramuscular injection |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer's labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | No \(Limited\) Human Data - Probably Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1. 使用前應先充分搖勻。 2. 應以肌肉注射的方式施打於上臂三角肌部位。 |

